ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

84 hedge funds and large institutions have $78M invested in Aclaris Therapeutics in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 27 reducing their positions, and 22 closing their positions.

Holders
84
Holders Change
-11
Holders Change %
-11.58%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
33
Reduced
27
Closed
22
Calls
–
Puts
$414K
Net Calls
-$414K
Net Calls Change
-$194K

Top Buyers

1
ECM
1
Endurant Capital Management
California
$3.57M
2
Man Group
2
Man Group
United Kingdom
$4.51M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.53M
4
Deutsche Bank
4
Deutsche Bank
Germany
$992K
5
RSCM
5
Rock Springs Capital Management
Maryland
$4.44M

Top Sellers

1
BC
1
Broadfin Capital
New York
$0
2
DM
2
Deerfield Management
New York
$8.72M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$1.47M
4
CIA
4
Capital Impact Advisors
Massachusetts
$0
5
BCP
5
Berylson Capital Partners
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SEI Investments
101
SEI Investments
Pennsylvania
– -$18K -3,277 Closed
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
– -$11K -1,818 Closed
TRCT
103
Tower Research Capital (TRC)
New York
– -$6K -946 Closed
1 2 3 4
5